Barclays Starts Karyopharm Therapeutics (KPTI) at Overweight

March 4, 2020 4:41 AM EST
Get Alerts KPTI Hot Sheet
Price: $6.10 -0.16%

Rating Summary:
    11 Buy, 3 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 13 | New: 52
Trade Now! 
Join SI Premium – FREE

Barclays analyst Peter Lawson initiates coverage on Karyopharm Therapeutics (NASDAQ: KPTI) with a Overweight rating and a price target of $30.00.


For an analyst ratings summary and ratings history on Karyopharm Therapeutics click here. For more ratings news on Karyopharm Therapeutics click here.


Shares of Karyopharm Therapeutics closed at $24.68 yesterday.


You May Also Be Interested In





Related Categories

New Coverage